SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.80-0.1%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bluegreen who wrote (6793)7/25/1998 10:08:00 AM
From: aknahow  Read Replies (1) of 17367
 
For reporting purposes only as of July 15 short interest was up 6% to 1,207,241 vs 1,135690 with average daily volume given as 174,040.

BTW I was surprised they continued the vaccine program. Your conclusion is correct, if Neuprex works to cure meningococcemia it will be used even if it is very expensive. Can a politician remain in office if nothing is done to assure the cure is used? Don't answer, let the politicians answer., or RobertS.

If Neuprex works on meningococcemia do you think doctors will not be eager to try it on sepsis?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext